Athanor Capital’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q1 | – | Sell |
-12,022
| Closed | -$1.15M | – | 928 |
|
2020
Q4 | $1.15M | Sell |
12,022
-14,296
| -54% | -$1.37M | 0.03% | 236 |
|
2020
Q3 | $2.53M | Buy |
26,318
+11,865
| +82% | +$1.14M | 0.1% | 101 |
|
2020
Q2 | $1.76M | Buy |
+14,453
| New | +$1.76M | 0.09% | 115 |
|
2020
Q1 | – | Sell |
-13,000
| Closed | -$1.4M | – | 256 |
|
2019
Q4 | $1.4M | Buy |
13,000
+1,900
| +17% | +$204K | 0.06% | 107 |
|
2019
Q3 | $1M | Buy |
+11,100
| New | +$1M | 0.06% | 108 |
|